NEUROENDOCRINE RESPONSES TO D-FENFLURAMINE AND INSULIN-INDUCED HYPOGLYCEMIA IN CHRONIC FATIGUE SYNDROME

被引:80
|
作者
BEARN, J
ALLAIN, T
COSKERAN, P
MUNRO, N
BUTLER, J
MCGREGOR, A
WESSELY, S
机构
[1] INST PSYCHIAT, DEPT PSYCHIAT, LONDON SE5 8AF, ENGLAND
[2] UNIV LONDON KINGS COLL, SCH MED & DENT, DEPT MED, LONDON WC2R 2LS, ENGLAND
[3] UNIV LONDON KINGS COLL, SCH MED & DENT, DEPT PSYCHOL MED, LONDON WC2R 2LS, ENGLAND
[4] UNIV LONDON KINGS COLL, SCH MED & DENT, DEPT CLIN BIOCHEM, LONDON WC2R 2LS, ENGLAND
[5] MIDDLESEX HOSP, DEPT NEUROL, LONDON W1N 8AA, ENGLAND
基金
英国医学研究理事会; 英国惠康基金;
关键词
CHRONIC FATIGUE SYNDROME; CORTISOL; GROWTH HORMONE; PROLACTIN; D-FENFLURAMINE; HYPOGLYCEMIA;
D O I
10.1016/0006-3223(94)00121-I
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Chronic fatigue syndrome (CFS) is a disorder characterized by severe physical and mental fatigue and fatiguability of central rather than peripheral origin. We hypothesized that CFS is mediated by changes in hypothalamopituitary function and so measured the adrenocorticotrophic hormone (ACTH), cortisol, growth hormone, and prolactin responses to insulin-induced hypoglycemia, and the ACTH, cortisol, and prolactin responses to serotoninergic stimulation with dexfenfluramine in nondepressed CFS patients and normal controls. We have shown attenuated prolactin responses to hypoglycemia in CFS. There was also a greater ACTH response and higher peak ACTH concentrations (36.44 +/- 4.45 versus 25.60 +/- 2.78 pg ml), whereas cortisol responses did not differ, findings that are compatible with impaired adrenal cortical function. This study provided evidence for both pituitary and adrenal cortical impairment in CFS and further studies are merited to both confirm and determine more precisely their neurobiological basis so that rational treatments can be evolved.
引用
收藏
页码:245 / 252
页数:8
相关论文
共 50 条
  • [1] Feeding and neuroendocrine responses after recurrent insulin-induced hypoglycemia
    Sanders, NM
    Figlewicz, DP
    Taborsky, GJ
    Wilkinson, CW
    Daumen, W
    Levin, BE
    PHYSIOLOGY & BEHAVIOR, 2006, 87 (04) : 700 - 706
  • [2] The neuroendocrine response to d-fenfluramine in women with premenstrual depression
    Bancroft, J
    Cook, A
    JOURNAL OF AFFECTIVE DISORDERS, 1995, 36 (1-2) : 57 - 64
  • [3] BEHAVIORAL AND NEUROENDOCRINE RESPONSES TO D-FENFLURAMINE IN RATS TREATED WITH NEUROTOXIC AMPHETAMINES
    SERIES, HG
    LEMASURIER, M
    GARTSIDE, SE
    FRANKLIN, M
    SHARP, T
    JOURNAL OF PSYCHOPHARMACOLOGY, 1995, 9 (03) : 214 - 222
  • [4] SEROTONERGIC FUNCTION IN PANIC DISORDER ENDOCRINE RESPONSES TO D-FENFLURAMINE
    JUDD, FK
    APOSTOLOPOULOS, M
    BURROWS, GD
    NORMAN, TR
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 1994, 18 (02) : 329 - 337
  • [5] CONTRASTING NEUROENDOCRINE RESPONSES IN DEPRESSION AND CHRONIC FATIGUE SYNDROME
    CLEARE, AJ
    BEARN, J
    ALLAIN, T
    MCGREGOR, A
    WESSELY, S
    MURRAY, RM
    OKEANE, V
    JOURNAL OF AFFECTIVE DISORDERS, 1995, 34 (04) : 283 - 289
  • [6] Somatotropic, lactotropic and adrenocortical responses to insulin-induced hypoglycemia in patients with rheumatoid arthritis
    Rovensky, J
    Bakosová, J
    Koska, J
    Ksinantová, L
    Jezová, D
    Vigas, M
    NEUROENDOCRINE IMMUNE BASIS OF THE RHEUMATIC DISEASES II, PROCEEDINGS, 2002, 966 : 263 - 270
  • [7] THE EFFECTS OF D-FENFLURAMINE ON MOOD AND PERFORMANCE, AND ON NEUROENDOCRINE INDICATORS OF 5-HT FUNCTION
    BOND, AJ
    FEIZOLLAH, S
    LADER, MH
    JOURNAL OF PSYCHOPHARMACOLOGY, 1995, 9 (01) : 1 - 8
  • [8] Neuroendocrine effects of d-fenfluramine and bromocriptine following repeated smoked cocaine in humans
    Haney, M
    Ward, AS
    Gerra, G
    Foltin, RW
    DRUG AND ALCOHOL DEPENDENCE, 2001, 64 (01) : 63 - 73
  • [9] PANCREATIC AND PITUITARY HORMONAL RESPONSES TO INSULIN-INDUCED HYPOGLYCEMIA DURING MUSCARINIC CHOLINERGIC BLOCKADE IN MAN
    FISHER, BM
    HEPBURN, DA
    FRIER, BM
    MORTON, JJ
    BEASTALL, GH
    GRAY, CE
    BUCHANAN, KD
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1992, 22 (09) : 614 - 618
  • [10] ORAL D-FENFLURAMINE AND NEUROENDOCRINE CHALLENGE - PROBLEMS WITH THE 30 MG DOSE IN MEN
    GOODWIN, GM
    MURRAY, CL
    BANCROFT, J
    JOURNAL OF AFFECTIVE DISORDERS, 1994, 30 (02) : 117 - 122